US Patent

US11072586 — Solid state forms of eltrombopag choline

Method of Use · Assigned to Assia Chemical Industries Ltd · Expires 2038-11-05 · 12y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent discloses solid state forms of eltrombopag choline, processes for preparing them, and pharmaceutical compositions.

USPTO Abstract

Solid state forms of Eltrombopag choline, processes for preparation thereof and pharmaceutical compositions thereof are disclosed.

Drugs covered by this patent

eltrombopag-choline (ELTROMBOPAG CHOLINE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3936`	—	eltrombopag-choline
`U-3937`	—	eltrombopag-choline
`U-3937`	—	eltrombopag-choline
`U-3937`	—	eltrombopag-choline

Patent Metadata

Patent number: US11072586
Jurisdiction: US
Classification: Method of Use
Expires: 2038-11-05
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Assia Chemical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.